Table 1

Summary of processed PCA data by year (drugs in Chapters 1–15 only)

YearDistinct count of drug nameItemsItems per 1000CostInflation-
corrected cost
Inflation-
corrected
cost per 1000
nnnChange
(%)
£2016 £2016 £Change
(%)
19986338497.0 million10 180£4440 million£6280 million£128 626
19996587513.4 million10 471+2.9£5011 million£6999 million£142 746+11.0
20006613535.1 million10 868+3.8£5284 million£7318 million£148 648+4.1
20016754569.2 million11 510+5.9£5784 million£7914 million£160 049+7.7
20026834598.6 million12 050+4.7£6487 million£8768 million£176 491+10.3
20036893630.3 million12 625+4.8£7113 million£9488 million£190 035+7.7
20046912666.0 million13 268+5.1£7645 million£10 063 million£200 482+5.5
20056907698.8 million13 808+4.1£7452 million£9609 million£189 875−5.3
20066810728.4 million14 292+3.5£7660 million£9655 million£189 436−0.2
20077056771.8 million15 022+5.1£7810 million£9614 million£187 112−1.2
20087202816.7 million15 762+4.9£7716 million£9174 million£177 047−5.4
20097401859.2 million 16 461+4.4£7892 million£9176 million£175 805−0.7
201011 703898.4 million17 065+3.7£8162 million£9193 million£174 636−0.7
201111 751931.6 million17 541+2.8£8101 million£8734 million£164 457−5.8
201212 207968.9 million18 112+3.3£7802 million£8176 million£152 836−7.1
201312 318996.2 million18 494+2.1£7846 million£8022 million£148 920−2.6
201412 5761027.0 million18 908+2.2£8022 million£8078 million£148 718−0.1
201512 8751043.5 million19 046+0.7£8403 million£8461 million£154 444+3.9
201613 2851060.9 million19 196+0.8£8284 million£8284 million£149 892−2.9
Total22 49614 810.9 million2 84 680+3.6£1 36 914 million£1 63 006 million£3 160 254+1.0
  • ‘Drug name’ is the field describing the presentation of each drug, that is, its formulation, dose and product name. Costs represent net ingredient cost (see box 1). ‘Change’ is the year-on-year change.

  • PCA, prescription cost analysis.